For example, FGFR1-amplified lung cancer cell lines exhibit increased FGFR1 protein expression compared to non-FGFR1-amplified cell lines and are sensitive to shRNA-mediated knockdown or pharmacological inhibition of FGFR1 [36]. This evidence concerns the gene FGFR1 and lung carcinoma.